UW Medicine 2nd International Symposium on Merkel Cell Carcinoma 2022
Format: 30 videos + 39 pdfs, size: 9.21 GB
Course Audience: oncologist
Overview:
Date & LocationMonday, April 25, 2022, 7:00 AM – Tuesday, April 26, 2022, 4:00 PM, Graduate Hotel, Seattle, WA
OverviewThe 2nd International Symposium on Merkel Cell Carcinoma (MCC) is designed to explore emerging data that may allow improvements in understand the basic biology that drives this disease, clinical guidelines, and to develop innovative approaches. Updates from the most recent clinical guidelines as well as emerging data regarding MCC biology are highlighted in plenary sessions. The educational purpose of this symposium is to disseminate emerging data and to advance MCC research through a stimulating and collaborative meeting.
The need for clinicians to continuously stay abreast of developments and current standards of care in the field of MCC is challenging because it is so rapidly evolving. Many clinicians are not familiar with how MCC differs from other skin cancers in its optimal management.
This activity will offer comprehensive reviews of the established standards of care and recent clinical advances in the field of MCC management, national cancer guidelines, and treatment recommendations in various clinical settings.
ObjectivesUpon completion of this activity, attendees should be able to:- Address the outstanding questions in MCC basic biology and how they can lead to improvements in clinical care.
- Identify the current clinical MCC biomarkers of disease burden and how to interpret those.
- Review and discuss the updated national MCC clinical guidelines.
WHO SHOULD ATTEND
Healthcare providers including MDs, DOs, PhDs, other healthcare professionals, and scientists interested in MCC.
‘Immunotherapy for solid organ transplant recipients with advanced MCC and other skin cancers (Video MP4 Format)
‘Immunotherapy for solid organ transplant recipients with advanced MCC and other skin cancers (PDF Format)Ablative Radiation Therapy for Merkel Cell Carcinoma (Video MP4 Format)Ablative Radiation Therapy for Merkel Cell Carcinoma (PDF Format)Abstract- Development of a Merkel polyomavirus-specific T cell receptor analysis tool to guide cancer immunotherapy (Video MP4 Format)Abstract- Development of a Merkel polyomavirus-specific T cell receptor analysis tool to guide cancer immunotherapy (PDF Format)Abstract- Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy (Video MP4 Format)Abstract- Impact of duration of immunotherapy on clinical outcomes in advanced Merkel cell carcinoma patients responding to first-line immunotherapy (PDF Format)Abstract- MCPyV ALTO is silenced in -virus-positive Merkel cell carcinoma and suppresses tumorigenesis (PDF Format)Abstract- Merkel polyoma virus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma (Video MP4 Format)Abstract- Merkel polyoma virus specific transgenic T cell receptor therapy in PD-1 inhibitor refractory Merkel cell carcinoma (PDF Format)Abstract- Real-world assessment of ipilimumab plus nivolumab in anti-PD-L1 PD-1- refractory Merkel 1 Cell Carcinoma (Video MP4 Format)Abstract- Real-world assessment of ipilimumab plus nivolumab in anti-PD-L1 PD-1- refractory Merkel 1 Cell Carcinoma (PDF Format)Abstract- The paranuclear dot in Merkel cell carcinoma, how does it form and what does it do. (Video MP4 Format)Abstract- The paranuclear dot in Merkel cell carcinoma, how does it form and what does it do. (PDF Format)Animal Models of MCC (Video MP4 Format)Animal Models of MCC (PDF Format)AST-008 and TLR9 agonists in Merkel cell carcinoma (Video MP4 Format)AST-008 and TLR9 agonists in Merkel cell carcinoma (PDF Format)Avelumab in mMMC- real-world data (Video MP4 Format)Avelumab in mMMC- real-world data (PDF Format)Can we harness T-cells specific for Merkel cell polyomavirus with therapuetic vaccination. (Video MP4 Format)Can we harness T-cells specific for Merkel cell polyomavirus with therapuetic vaccination. (PDF Format)Clues to the Origins of Merkel Cell Carcinoma (Video MP4 Format)Clues to the Origins of Merkel Cell Carcinoma (PDF Format)Contribution of Merkel Cell Polyomavirus to Merkel Cell Carcinoma (Video MP4 Format)Contribution of Merkel Cell Polyomavirus to Merkel Cell Carcinoma (PDF Format)Cross-sectional Imaging In Merkel Cell Carcinoma- Is Less More. (Video MP4 Format)Cross-sectional Imaging In Merkel Cell Carcinoma- Is Less More. (PDF Format)Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma (Video MP4 Format)Diagnostic Yield of Staging Brain MRI in Merkel Cell Carcinoma (PDF Format)Epigenetic and Genetic Determinants of Merkel Cell Carcinoma (Video MP4 Format)Epigenetic and Genetic Determinants of Merkel Cell Carcinoma (PDF Format)Featured Abstract- Virally mediated mechanisms of HLA class I loss in Merkel cell carcinoma and implications for viral epitope presentation (Video MP4 Format)Featured Abstract- Virally mediated mechanisms of HLA class I loss in Merkel cell carcinoma and implications for viral epitope presentation (PDF Format)Immunotherapy Platform and Related-omics (Video MP4 Format)Immunotherapy Platform and Related-omics (PDF Format)MCC Immunotherapy- Lessons Learnt and Unmet Needs (Video MP4 Format)MCC Immunotherapy- Lessons Learnt and Unmet Needs (PDF Format)MCPyV-specific T cell discovery for adoptive T cell therapy (Video MP4 Format)MCPyV-specific T cell discovery for adoptive T cell therapy (PDF Format)Mechanisms of Oncogenesis- MCC Cell of Origin (Video MP4 Format)Mechanisms of Oncogenesis- MCC Cell of Origin (PDF Format)Merkel Cell Carcinoma in France- Characteristics of a Cohort of 1300 Patients (Video MP4 Format)Merkel Cell Carcinoma in France- Characteristics of a Cohort of 1300 Patients (PDF Format)MJ2207 CME Questions Monday with ANSWERS (PDF Format)MJ2207 CME Questions Monday (PDF Format)MJ2207 CME Questions Tuesday with ANSWERS (PDF Format)MJ2207 CME Questions Tuesday (PDF Format)Neoadjuvant PD-1 Pathway Blockade for MCC- a window into treatment response and primary resistance (Video MP4 Format)Neoadjuvant PD-1 Pathway Blockade for MCC- a window into treatment response and primary resistance (PDF Format)Q&A Summary (PDF Format)Randomized Phase II Study of NIVO + IPI vs. NIVO + IPI + SBRT in Metastatic or Recurrent Merkel Cell Carcinoma (Video MP4 Format)Randomized Phase II Study of NIVO + IPI vs. NIVO + IPI + SBRT in Metastatic or Recurrent Merkel Cell Carcinoma (PDF Format)Real world management of MCC patients in France (Video MP4 Format)Real world management of MCC patients in France (PDF Format)Registration & Breakfast (PDF Format)Role of radiotherapy in Merkel cell cancer (Video MP4 Format)Role of radiotherapy in Merkel cell cancer (PDF Format)State of the Field- Merkel Cell Carcinoma (PDF Format)Surgery – Adjuvant RT (Video MP4 Format)Surgery – Adjuvant RT (PDF Format)Systemic therapies for metastatic Merkel cell carcinoma (Video MP4 Format)Systemic therapies for metastatic Merkel cell carcinoma (PDF Format)Transcriptional Responses to Type II Interferon Treatment in Merkel cell carcinoma (Video MP4 Format)Transcriptional Responses to Type II Interferon Treatment in Merkel cell carcinoma (PDF Format)Update on Australian MCC Clinical Trials (Video MP4 Format)Update on Australian MCC Clinical Trials (PDF Format)Welcome Remarks & Course Intro (PDF Format)